Publication | Open Access

Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV

MedicineHuman RetrovirusAntiviral Drug DevelopmentAntiviral TherapyMolecular BiologyAntiviral DrugHivPharmacological EvaluationPharmacologyAntiviral CompoundDrug Discovery